These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16809035)

  • 1. Correlation between brain/plasma ratios and efficacy in neuropathic pain models of selective metabotropic glutamate receptor 1 antagonists.
    Zheng GZ; Bhatia P; Kolasa T; Patel M; El Kouhen OF; Chang R; Uchic ME; Miller L; Baker S; Lehto SG; Honore P; Wetter JM; Marsh KC; Moreland RB; Brioni JD; Stewart AO
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4936-40. PubMed ID: 16809035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationship of triazafluorenone derivatives as potent and selective mGluR1 antagonists.
    Zheng GZ; Bhatia P; Daanen J; Kolasa T; Patel M; Latshaw S; El Kouhen OF; Chang R; Uchic ME; Miller L; Nakane M; Lehto SG; Honore MP; Moreland RB; Brioni JD; Stewart AO
    J Med Chem; 2005 Nov; 48(23):7374-88. PubMed ID: 16279797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR studies of triazafluorenone inhibitors of metabotropic glutamate receptor subtype 1.
    Nataraja Sekhar Y; Ravikumar M; Ravi Shashi Nayana M; Mallena SC; Kishore Kumar M
    Eur J Med Chem; 2008 May; 43(5):1025-34. PubMed ID: 17822809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tricyclic thienopyridine-pyrimidones/thienopyrimidine-pyrimidones as orally efficacious mGluR1 antagonists for neuropathic pain.
    Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Li C; Heimark L; Pramanik B; Grilli M; Bertorelli R; Lozza G; Reggiani A
    Bioorg Med Chem Lett; 2009 Jun; 19(12):3199-203. PubMed ID: 19433355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of the metabotropic glutamate receptor 1 antagonist compared with those of the metabotropic glutamate receptor 5 antagonist and metabotropic glutamate receptor 2/3 agonist in rodents: detailed investigations with a selective allosteric metabotropic glutamate receptor 1 antagonist, FTIDC [4-[1-(2-fluoropyridine-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl-3,6-dihydropyridine-1(2H)-carboxamide].
    Satow A; Maehara S; Ise S; Hikichi H; Fukushima M; Suzuki G; Kimura T; Tanak T; Ito S; Kawamoto H; Ohta H
    J Pharmacol Exp Ther; 2008 Aug; 326(2):577-86. PubMed ID: 18487514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A-ring modifications on the triazafluorenone core structure and their mGluR1 antagonist properties.
    Sasikumar TK; Qiang L; Burnett DA; Greenlee WJ; Li C; Grilli M; Bertorelli R; Lozza G; Reggiani A
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2474-7. PubMed ID: 20346665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3-Phenyl-5-isothiazole carboxamides with potent mGluR1 antagonist activity.
    Fisher MJ; Backer RT; Barth VN; Garbison KE; Gruber JM; Heinz BA; Iyengar S; Hollinshead SP; Kingston A; Kuklish SL; Li L; Nisenbaum ES; Peters SC; Phebus L; Simmons RM; van der Aar E
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2514-7. PubMed ID: 22386665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery and biological profile of 4-(1-aryltriazol-4-yl)-tetrahydropyridines as an orally active new class of metabotropic glutamate receptor 1 antagonist.
    Ito S; Satoh A; Nagatomi Y; Hirata Y; Suzuki G; Kimura T; Satow A; Maehara S; Hikichi H; Hata M; Kawamoto H; Ohta H
    Bioorg Med Chem; 2008 Nov; 16(22):9817-29. PubMed ID: 18849168
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of aryl isoxazole derivatives as metabotropic glutamate receptor 1 antagonists: a potential treatment for neuropathic pain.
    Cho GH; Kim T; Son WS; Seo SH; Min SJ; Cho YS; Keum G; Jeong KS; Koh HY; Lee J; Pae AN
    Bioorg Med Chem Lett; 2015 Mar; 25(6):1324-8. PubMed ID: 25677662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antinociceptive profile of a selective metabotropic glutamate receptor 1 antagonist YM-230888 in chronic pain rodent models.
    Kohara A; Nagakura Y; Kiso T; Toya T; Watabiki T; Tamura S; Shitaka Y; Itahana H; Okada M
    Eur J Pharmacol; 2007 Sep; 571(1):8-16. PubMed ID: 17597604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, in vitro pharmacology, structure-activity relationships, and pharmacokinetics of 3-alkoxy-2-amino-6-fluorobicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives as potent and selective group II metabotropic glutamate receptor antagonists.
    Nakazato A; Sakagami K; Yasuhara A; Ohta H; Yoshikawa R; Itoh M; Nakamura M; Chaki S
    J Med Chem; 2004 Aug; 47(18):4570-87. PubMed ID: 15317467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repetitive activation of glutamatergic inputs evokes a long-lasting excitation in rat globus pallidus neurons in vitro.
    Kaneda K; Kita T; Kita H
    J Neurophysiol; 2007 Jan; 97(1):121-33. PubMed ID: 17228082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3-[Substituted]-5-(5-pyridin-2-yl-2H-tetrazol-2-yl)benzonitriles: identification of highly potent and selective metabotropic glutamate subtype 5 receptor antagonists.
    Tehrani LR; Smith ND; Huang D; Poon SF; Roppe JR; Seiders TJ; Chapman DF; Chung J; Cramer M; Cosford ND
    Bioorg Med Chem Lett; 2005 Nov; 15(22):5061-4. PubMed ID: 16183275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benzazoles as allosteric potentiators of metabotropic glutamate receptor 2 (mGluR2): efficacy in an animal model for schizophrenia.
    Govek SP; Bonnefous C; Hutchinson JH; Kamenecka T; McQuiston J; Pracitto R; Zhao LX; Gardner MF; James JK; Daggett LP; Rowe BA; Schaffhauser H; Bristow LJ; Campbell UC; Rodriguez DE; Vernier JM
    Bioorg Med Chem Lett; 2005 Sep; 15(18):4068-72. PubMed ID: 16005222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships for the linker in a series of pyridinyl-alkynes that are antagonists of the metabotropic glutamate receptor 5 (mGluR5).
    Bach P; Nilsson K; Svensson T; Bauer U; Hammerland LG; Peterson A; Wållberg A; Osterlund K; Karis D; Boije M; Wensbo D
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4788-91. PubMed ID: 16837196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isoxazolopyridone derivatives as allosteric metabotropic glutamate receptor 7 antagonists.
    Nakamura M; Kurihara H; Suzuki G; Mitsuya M; Ohkubo M; Ohta H
    Bioorg Med Chem Lett; 2010 Jan; 20(2):726-9. PubMed ID: 20005101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-beta-carbolines: a new class of orally bioavailable mGluR1 antagonists.
    Di Fabio R; Micheli F; Alvaro G; Cavanni P; Donati D; Gagliardi T; Fontana G; Giovannini R; Maffeis M; Mingardi A; Tranquillini ME; Vitulli G
    Bioorg Med Chem Lett; 2007 Apr; 17(8):2254-9. PubMed ID: 17276684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel heteroarylazoles that are metabotropic glutamate subtype 5 receptor antagonists with anxiolytic activity.
    Roppe J; Smith ND; Huang D; Tehrani L; Wang B; Anderson J; Brodkin J; Chung J; Jiang X; King C; Munoz B; Varney MA; Prasit P; Cosford ND
    J Med Chem; 2004 Sep; 47(19):4645-8. PubMed ID: 15341479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and biological evaluation of tetrahydrothieno[2,3-c]pyridine derivatives as selective metabotropic glutamate receptor 1 antagonists for the potential treatment of neuropathic pain.
    Nam M; Kim T; Kwak J; Seo SH; Ko MK; Lim EJ; Min SJ; Cho YS; Keum G; Baek DJ; Lee J; Pae AN
    Eur J Med Chem; 2015 Jun; 97():245-58. PubMed ID: 25984841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting compound selectivity by self-organizing maps: cross-activities of metabotropic glutamate receptor antagonists.
    Noeske T; Sasse BC; Stark H; Parsons CG; Weil T; Schneider G
    ChemMedChem; 2006 Oct; 1(10):1066-8. PubMed ID: 16986201
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.